Treatment challenges and outcomes of older patients with acute myeloid leukemia from India

被引:1
作者
Singh, Suvir [1 ]
Lionel, Sharon [2 ]
Jain, Hasmukh [3 ]
Rajendra, Akhil [4 ]
Nayak, Lingaraj [3 ]
Selvarajan, Sushil [2 ]
Samuel, Prasanna [5 ]
Ahmed, Rayaz [6 ]
Aggarwal, Narendra [6 ]
Ds, Pavitra [7 ]
Byreddy, Poojitha [7 ]
John, Mjoseph [7 ]
Mishra, Kundan [8 ]
Kumar, Suman [8 ]
Paul, Mobin [9 ]
Abraham, Latha K. [9 ]
Kayal, Smita [10 ]
Ganesan, Prasanth [10 ]
Philip, Chepsy C. [11 ]
Das, Damodar [12 ]
Sreeraj, V [13 ]
Mehta, Prashant [14 ]
Pk, Jayachandran [4 ]
Raghavan, Vineetha [15 ]
Bala, Stalin Chowdary [16 ]
Bharath, Ram S. [17 ]
Majumdar, Swaratika [18 ]
Prakash, Om [5 ]
Barath, U. [5 ]
Bagal, Bhausaheb [3 ]
Abraham, Aby [2 ]
Kapoor, Rajan [8 ]
Bhurani, Dinesh [6 ]
Sengar, Manju [3 ]
Mathews, Vikram [2 ]
机构
[1] Dayanand Med Coll, Dept Clin Haematol, Ludhiana 141001, India
[2] Christian Med Coll & Hosp, Vellore, India
[3] Tata Mem Hosp, Mumbai, India
[4] Canc Inst Adyar, Chennai, India
[5] CMC, Dept Biostat, Vellore, India
[6] Rajiv Gandhi Canc Inst & Res Ctr, New Delhi, India
[7] Christian Med Coll & Hosp, Ludhiana, India
[8] Army Hosp Res & Referral, New Delhi, India
[9] Rajagiri Hosp, Kochi, India
[10] Jawaharlal Inst Postgrad Med Educ & Res, Pondicherry, India
[11] Believers Church Med Coll Hosp, Thiruvalla, India
[12] Guwahati Med Coll, Gauhati, India
[13] Amala Canc Hosp & Res Ctr, Trichur, India
[14] Asian Inst Med Sci AIMS, Faridabad, India
[15] Malabar Canc Ctr, Thalassery, Kerala, India
[16] Nizams Inst Med Sci NIMS, Hyderabad, India
[17] Narayana Hlth Hosp, Bengaluru, India
[18] Ramaiah Med Coll & Hosp RMCH, Bengaluru, India
关键词
AML; Leukemia; Cancer; Fungal; Chemotherapy; REAL-WORLD DATA; INTENSIVE CHEMOTHERAPY; SURVIVAL; AZACITIDINE; THERAPY; ADULTS; AML; AGE;
D O I
10.1007/s00277-024-05873-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Globally, overall survival (OS) of older patients with AML continues to be suboptimal with very little data from India. In a multicenter registry analysis, we evaluated 712 patients with AML older than 55 years. Only 323 (45.3%) underwent further treatment, of which 239 (74%) received HMAs, and 60 (18%) received intensive chemotherapy (IC). CR was documented in 39% of those receiving IC and 42% after HMAs. Overall, 100 (31%) patients died within 60 days of diagnosis, most commonly due to progressive disease (47%) or infections (30%). After a median follow-up of 176 days, 228 (76%) of patients had discontinued treatment. At one year from diagnosis, 211 (65%) patients had died, and the median OS was 186 days (IQR, 137-234). Only 12 (3.7%) patients underwent stem cell transplantation. Survival was significantly lower for those older than 60 years (p < 0.001). Patients who died had a higher median age (p = .027) and baseline WBC counts (p = .006). Our data highlights suboptimal outcomes in older AML patients, which are evident from 55 years of age onwards, making it necessary to evaluate HMA and targeted agent combinations along with novel consolidation strategies to improve survival in this high-risk population.
引用
收藏
页码:4079 / 4088
页数:10
相关论文
共 44 条
[1]   Management of Acute Myeloid Leukemia (AML) in Older Patients [J].
Abdallah, Maya ;
Xie, Zhuoer ;
Ready, Audrey ;
Manogna, Dharmini ;
Mendler, Jason H. ;
Loh, Kah Poh .
CURRENT ONCOLOGY REPORTS, 2020, 22 (10)
[2]  
Abuelgasim Khadega A, 2020, Leuk Res Rep, V14, P100206, DOI [10.1016/j.lrr.2020.100206, 10.1016/j.lrr.2020.100206]
[3]   Age and acute myeloid leukemia [J].
Appelbaum, FR ;
Gundacker, H ;
Head, DR ;
Slovak, ML ;
Willman, CL ;
Godwin, JE ;
Anderson, JE ;
Petersdorf, SH .
BLOOD, 2006, 107 (09) :3481-3485
[4]   The 2016 WHO classification of acute myeloid leukemia: What the practicing clinician needs to know [J].
Arber, Daniel A. .
SEMINARS IN HEMATOLOGY, 2019, 56 (02) :90-95
[5]   Improved outcome for AML patients over the years 2000-2014 [J].
Bertoli, Sarah ;
Tavitian, Suzanne ;
Huynh, Anne ;
Borel, Cecile ;
Guenounou, Sarah ;
Luquet, Isabelle ;
Delabesse, Eric ;
Sarry, Audrey ;
Laurent, Guy ;
Attal, Michel ;
Huguet, Francoise ;
Berard, Emilie ;
Recher, Christian .
BLOOD CANCER JOURNAL, 2017, 7
[6]   Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia [J].
DiNardo, C. D. ;
Jonas, B. A. ;
Pullarkat, V. ;
Thirman, M. J. ;
Garcia, J. S. ;
Wei, A. H. ;
Konopleva, M. ;
Doehner, H. ;
Letai, A. ;
Fenaux, P. ;
Koller, E. ;
Havelange, V. ;
Leber, B. ;
Esteve, J. ;
Wang, J. ;
Pejsa, V. ;
Hajek, R. ;
Porkka, K. ;
Illes, A. ;
Lavie, D. ;
Lemoli, R. M. ;
Yamamoto, K. ;
Yoon, S. -S. ;
Jang, J. -H. ;
Yeh, S. -P. ;
Turgut, M. ;
Hong, W. -J. ;
Zhou, Y. ;
Potluri, J. ;
Pratz, K. W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (07) :617-629
[7]   Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care [J].
Doehner, Hartmut ;
Dolnik, Anna ;
Tang, Lin ;
Seymour, John F. ;
Minden, Mark D. ;
Stone, Richard M. ;
Bernal del Castillo, Teresa ;
Al-Ali, Haifa Kathrin ;
Santini, Valeria ;
Vyas, Paresh ;
Beach, C. L. ;
MacBeth, Kyle J. ;
Skikne, Barry S. ;
Songer, Steve ;
Tu, Nora ;
Bullinger, Lars ;
Dombret, Herve .
LEUKEMIA, 2018, 32 (12) :2546-2557
[8]  
Ganapule A, 2017, J GLOB ONCOL, V3, P773, DOI 10.1200/JGO.2016.006650
[9]   Role of allotransplantation in older patients with AML [J].
Ganser, Arnold .
BLOOD, 2023, 141 (03) :217-218
[10]   A Prospective Observational Multi-institutional Study on Invasive Fungal Infections Following Chemotherapy for Acute Myeloid Leukemia (MISFIC Study): A Real World Scenario from India [J].
George, Biju ;
Menon, Hari ;
Bhurani, Dinesh ;
Damodar, Sharat ;
Apte, Shashi ;
Seth, Tulika ;
Sharma, Ajay ;
Shyam, Radhe ;
Malhotra, Pankaj ;
Easow, Jose ;
Lakshmi, Kavitha M. ;
Agrawal, Narendra ;
Sengar, Manju ;
Nataraj, K. S. ;
Ahmed, Rayaz ;
Sharma, Sanjeevan ;
Khadwal, Alka ;
Prakash, Gaurav ;
Abraham, Aby ;
Devasia, Anup ;
Korula, Anu ;
Mathews, Vikram .
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2020, 36 (01) :97-103